PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 3715-3721

  Castaño Rodríguez, Natalia ^a   Kaakoush, Nadeem O ^a   Goh, Khean Lee ^b   Fock, Kwong Ming ^c   Chionh, Yok Teng ^d   Sutton, Philip ^d,e   Mitchell, Hazel M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Helicobacter pylori; PAR 1 polymorphism; Protease activated receptors; Stomach neoplasm

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 1;

AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STOMACH CANCER;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, PAR-1; STOMACH NEOPLASMS;

EID: 84866992360     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ferlay J SH, Bray F, Forman D, Mathers C and Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer., 2010.
2. Chia KS, Lee JJ, Wong JL, Gao W, Lee HP and Shanmugaratnam K: Cancer incidence in Singapore, 1998 to 1999. Ann Acad Med Singapore 31: 745-750, 2002. (Pubitemid 36216158)
3. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
4. Goh KL, Cheah PL, Md N, Quek KF and Parasakthi N: Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: A prospective case control study. Am J Gastroenterol 102: 40-45, 2007. (Pubitemid 46072041)
5. Gonzalez CA, Sala N and Capella G: Genetic susceptibility and gastric cancer risk. Int J Cancer 100: 249-260, 2002. (Pubitemid 34728981)
6. Kusters JG, van Vliet AH and Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490, 2006. (Pubitemid 44134306)
7. Li H, Stoicov C, Cai X, Wang TC and Houghton J: Helicobacter and gastric cancer disease mechanisms: host response and disease susceptibility. Curr Gastroenterol Rep 5: 459-467, 2003. (Pubitemid 38915045)
8. Lochhead P and El-Omar EM: Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 21: 281-297, 2007. (Pubitemid 46421914)
9. Wroblewski LE, Peek RM Jr. and Wilson KT: Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23: 713-739, 2010.
10. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
11. Macarthur M, Hold GL and El-Omar EM: Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Amer J Physiol Gastroint Liver Physiol 286: G515-520, 2004. (Pubitemid 38374969)
12. Dery O, Corvera CU, Steinhoff M and Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274: C1429-1452, 1998.
13. Cirino G and Vergnolle N: Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulation. Current Opinion Pharmacol 6 : 428-434, 2006.
14. Kawabata A, Nishikawa H, Saitoh H, Nakaya Y, Hiramatsu K, Kubo S, Nishida M, Kawao N, Kuroda R, Sekiguchi F, Kinoshita M, Kakehi K, Arizono N, Yamagishi H and Kawai K: A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 126: 208-219, 2004. (Pubitemid 38040737)
15. Toyoda N, Gabazza EC, Inoue H, Araki K, Nakashima S, Oka S, Taguchi Y, Nakamura M, Suzuki Y, Taguchi O, Imoto I, Suzuki K and Adachi Y: Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol 38: 253-259, 2003. (Pubitemid 36469984)
16. Wee JL, Chionh YT, Ng GZ, Harbour SN, Allison C, Pagel CN, Mackie EJ, Mitchell HM, Ferrero RL and Sutton P: Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology 138: 573-582, 2010.
17. Yoshida N and Yoshikawa T: Basic and translational research on proteinase-activated receptors: implication of proteinase/proteinase-activated receptor in gastrointestinal inflammation. J Pharmacol Sci 108: 415-421, 2008.
18. Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S and Yamaguchi A: The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion. BMC Cancer 10: 443, 2010.
19. Kim SJ, Shin JY, Lee KD, Bae YK, Choi IJ, Park SH and Chun KH: Galectin-3 facilitates cell motility in gastric cancer by upregulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PLoS One 6: e25103, 2011.
20. Darmoul D, Gratio V, Devaud H, Lehy T and Laburthe M: Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162: 1503-1513, 2003. (Pubitemid 36512832)
21. Darmoul D, Marie JC, Devaud H, Gratio V and Laburthe M: Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 85: 772-779, 2001. (Pubitemid 32929479)
22. Arnaud E, Nicaud V, Poirier O, Rendu F, Alhenc-Gelas M, Fiessinger JN, Emmerich J and Aiach M: Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol 20: 585-592, 2000. (Pubitemid 30086120)
23. Dupont A, Fontana P, Bachelot-Loza C, Reny JL, Bieche I, Desvard F, Aiach M and Gaussem P: An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 101: 1833-1840, 2003. (Pubitemid 36237581)
24. Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, Zhang W, Ning Y, Manegold PC, El-Khoueiry A, Iqbal S, Tang LH, Shah MA and Lenz HJ: Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol 21 : 78-86, 2010.
25. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, and Tytgat GN: Functional gastroduodenal disorders. Gut 45(Suppl 2): II37-42, 1999. (Pubitemid 29434811)
26. Mitchell H, English DR, Elliott F, Gengos M, Barrett JH, Giles GG and Forman D: Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer. Aliment Pharmacol Ther 28: 903-910, 2008.
27. Schmidt HM, Ha DM, Taylor EF, Kovach Z, Goh KL, Fock KM, Barrett JH, Forman D and Mitchell H: Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country. J Gastroenterol Hepatol 26: 1725-1732, 2011.
28. Martinelli A, Knapp S, Anstee Q, Worku M, Tommasi A, Zucoloto S, Goldin R and Thursz M: Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis. J Gastroenterol Hepatol 23: 1403-1409, 2008.
29. Hazbon MH and Alland D: Hairpin primers for simplified single-nucleotide polymorphism analysis of Mycobacterium tuberculosis and other organisms. J Clin Microbiol 42: 1236-1242, 2004. (Pubitemid 38332854)
30. Jurinke C, van den Boom D, Cantor CR and Koster H: The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 77: 57-74, 2002.
31. Oeth P BM, Park C, Kosman D, del Mistro G, van den Boom D, Jurinke C: iPLEX™ Assay: Increased Plexing Efficiency and Flexibility for MassARRAY® System Through Single Base Primer Extension with Mass-Modified Terminators. Sequenom, p. 12, 2005.
32. Excoffier LGL and Schneider S: Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online 1: 47-50, 2005.
33. Correa P: A human model of gastric carcinogenesis. Cancer Res 48: 3554-3560, 1988.
34. Razin E and Marx G: Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J Immunol 133: 3282-3285, 1984. (Pubitemid 15216505)
35. Jones A and Geczy CL: Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71: 236-241, 1990. (Pubitemid 20341224)
36. Sipponen P and Correa P: Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5: 213-219, 2002. (Pubitemid 36605884)
37. Furukawa H, Iwanaga T, Koyama H and Taniguchi H: Effect of sex hormones on the experimental induction of cancer in rat stomach - a preliminary study. Digestion 23: 151-155, 1982. (Pubitemid 12123957)
38. Palli D, Cipriani F, Decarli A, Galli M, Saieva C, Fraumeni JF Jr., Blot WJ and Buiatti E: Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 56: 812-815, 1994. (Pubitemid 24102745)
39. Fock KM: Helicobacter pylori infection--current status in Singapore. Ann Acad Med Singapore 26: 637-641, 1997.
40. Wong BC, Lam SK, Ching CK, Hu WH, Kwok E, Ho J, Yuen ST, Gao Z, Chen JS, Lai KC, Ong LY, Chen BW, Wang WH, Jiang XW, Hou XH and Lu JY: Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group. J Gastroenterol Hepatol 14: 120-125, 1999. (Pubitemid 29092868)
41. Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, Tan W, Wang G and Lin D: Role of CD14 promoter polymorphisms in Helicobacter pylori infection-related gastric carcinoma. Clin Cancer Res 13: 2362-2368, 2007. (Pubitemid 46698585)
42. Loh M, Koh KX, Yeo BH, Song CM, Chia KS, Zhu F, Yeoh KG, Hill J, Iacopetta B and Soong R: Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 45: 2562-2568, 2009.